Phase I Trial: T4 Immunotherapy of Head and Neck Cancer
King's College London
King's College London
European Institute of Oncology
Suzhou Genhouse Bio Co., Ltd.
Radboud University Medical Center
European Institute of Oncology
Irish Research Radiation Oncology Group
Guy's and St Thomas' NHS Foundation Trust
European Institute of Oncology
Mahidol University
University of Milan
Wellmarker Bio
University Medical Center Groningen
GCS Ramsay Santé pour l'Enseignement et la Recherche
Centre Leon Berard
West China Hospital
Ottawa Hospital Research Institute
Centre hospitalier de l'Université de Montréal (CHUM)
Regina Elena Cancer Institute
Kuwait Cancer Control Center
Sixth Affiliated Hospital, Sun Yat-sen University
Poitiers University Hospital
University Hospital, Ghent
University College, London
Guy's and St Thomas' NHS Foundation Trust
Sunnybrook Health Sciences Centre
Samsung Medical Center
Savana Research
Nanfang Hospital, Southern Medical University
National Cancer Institute, Naples
The Netherlands Cancer Institute
Rigshospitalet, Denmark
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Centre Georges Francois Leclerc
AronPharma Sp. z o. o.
Royal Marsden NHS Foundation Trust
Centre Leon Berard
Instituto Nacional de Cancer, Brazil
East and North Hertfordshire NHS Trust
Guy's and St Thomas' NHS Foundation Trust
Chang Gung Memorial Hospital
Chang Gung Memorial Hospital
Catholic University of the Sacred Heart
University Medical Center Groningen
East and North Hertfordshire NHS Trust
Tosk, Inc.
Massachusetts General Hospital
Nanfang Hospital, Southern Medical University
Assiut University
Johann Wolfgang Goethe University Hospital
Kineta Inc.